Search

everythinglearnresearchcommunity

for

Search:↓

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

A woman with lupus and Kikuchi-Fujimoto disease improved with treatment.

A woman with lupus had rare severe symptoms but improved with treatment.

It's unclear if COVID-19 vaccination causes SLE; more research is needed.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

A man had both alopecia areata and lichen planus, which is uncommon.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

The document lists dermatology topics across life stages and notes hair loss can affect self-esteem and early skin cancer treatment is crucial.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Traditional Chinese medicines with heavy metals can cause severe poisoning.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Most patients treated with low-dose alpha-interferon for malignant melanoma experienced skin side effects, with hair loss being the most frequent.

Hair can regrow after certain stem cells are lost because other stem cells can take over their role.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Eph/ephrin signaling is important for skin cell behavior and could be targeted to treat skin diseases.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

Toxic shock syndrome is caused by a complex interaction of bacterial toxins and the immune system, and understanding this can help improve diagnosis and treatment.

Tinea capitis is a common scalp infection causing hair loss, mostly in young children.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.